CRYSTAL TRABEL: Open Payments
NPI 1912480039 · HICKSVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| United Therapeutics Corporation | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| GENZYME CORPORATION | 2 | $34 |
| Grifols USA, LLC | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: DUPIXENT, NUCALA, Tyvaso, GLASSIA, Prolastin-C Liquid, OFEV, WINREVAIR, UPTRAVI.
Industry payments across OH — which companies pay providers there.
